Programmed Death Ligand 1 (PD-L1) Tumor Expression Is Associated with a Better Prognosis and Diabetic Disease in Triple Negative Breast Cancer Patients

Triple Negative Breast Cancers (TNBC) subtype is an aggressive disease with poor clinical outcome. The only treatment available is surgery followed by chemotherapy or radiotherapy. Programmed death-ligand 1 (PD-L1) is a trans-membrane protein expressed on a wide variety of cells including immune cel...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Mol Sci
Autors principals: Botti, Gerardo, Collina, Francesca, Scognamiglio, Giosuè, Rao, Federica, Peluso, Valentina, De Cecio, Rossella, Piezzo, Michela, Landi, Gabriella, De Laurentiis, Michelino, Cantile, Monica, Di Bonito, Maurizio
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2017
Matèries:
Communication
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5343992/
https://ncbi.nlm.nih.gov/pubmed/28230773
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms18020459
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars